Associate Director, Business Development, Corporate Development Transactions - China at Bristol-Myers Squibb

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Minimum education of a bachelor's degree; MBA, JD or other advanced business degree preferred
Minimum of five (5) to ten (10) years of business experience within the life sciences industry, business/corporate development, strategy, finance, investment banking, or management consulting
Experience in various biopharmaceutical Corporate Development transactions (M&A, divestitures, out licenses, etc.) and strategy
Ability to analyze and understand sales forecasts, P&Ls, risk analyses, and company valuations; strong understanding of discounted cash flow, net present value, internal rates of return and risk analysis techniques
Able to collect and integrate key business and scientific points across therapeutic areas into M&A target monitoring, evaluation and valuation
Proven ability to manage multiple projects efficiently and independently with supervision of Business Development leader

Responsibilities

Support key strategic Corporate Development efforts in the China market; 80% dedicated to global strategic efforts, 20% dedicated to China 2030 strategy
Support strategic evaluations and sourcing in how we leverage China’s biotech ecosystem to source innovation for BMS globally, providing points of view on sourced innovative assets in China, with the ability to present to the most senior BMS stakeholders
Demonstrate business acumen while collaborating closely with global Business Development Search and Evaluation (S&E), R&D, Finance, and Commercial stakeholders as well as external advisors
Facilitate and support active monitoring and surveillance work on a broad set of Corporate Development for global and China priorities
Support pre-transaction triage, diligence, evaluation, and tracking of Corporate Development and licensing opportunities (M&A, externalizations, and divestitures) working closely with our internal team and other key stakeholders
Support the Corporate Development deal process: Support project team interactions with functional representatives, including those from third parties (i.e. bankers, lawyers, accountants, and consultants, etc.)
Lead and manage the development, drafting, and execution of project team deliverables and recommendations
Ensure robustness of the overall Corporate Development process and complete deliverables under time-sensitive deadlines
Participate in the successful structuring, negotiation, and execution of Corporate Development transactions with supervision to successful completion
Support the delivery of business assessments and recommendations of Corporate Development opportunities including deal proposals, valuation, deal status, and key issues of the transaction to BMS governance bodies for endorsement
Collaborate with a broad range of BMS functions, including coordinating with internal stakeholders / external counterparts to ensure smooth execution and working with Transaction Legal on contracts
Responsible for coordinating team meetings, preparing agendas, and minutes for various BD related M&A teams as needed

Skills

Business Development

Corporate Development

M&A

Strategic Evaluation

Due Diligence

Deal Negotiation

Biotech Ecosystem

Stakeholder Management

R&D Collaboration

Finance Collaboration

Commercial Strategy

Market Surveillance

Licensing Agreements

Transaction Triage

Innovation Sourcing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free